Clinical trial
Montelukast in the Treatment of Duodenal Eosinophilia
NCT00148603 · Children's Mercy Hospital Kansas City, Other · Completed
Key facts
| NCT number | NCT00148603 |
|---|---|
| Title | Montelukast in the Treatment of Duodenal Eosinophilia |
| Official title | Montelukast in the Treatment of Duodenal Eosinophilia in Children With Dyspepsia: Effect on Eosinophil Density and Activation in Relation to Pharmacokinetics |
| Lead sponsor | Children's Mercy Hospital Kansas City, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Eosinophilic Gastroenteritis, Dyspepsia |
| Intervention type | Drug |
| Interventions | montelukast |
| Enrollment | 24 |
| Start date | Sep 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Dec 29, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: